AnalyzeDirect Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT, Meyers CM. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. October 2011;6(10):2508-2515.
Full Text – Open Access
Publication Date
October 2011
How Analyze was Used
“Image analysis was implemented and performed in the Analyze software system.”
Keywords
Angiotensin II Type 1 Receptor Blockers/therapeutic use
Angiotensin-Converting Enzyme Inhibitors/therapeutic use
Double-Blind Method
Female
Heart Ventricles/drug effects/pathology
Humans
Hypertension/drug therapy/epidemiology/etiology
Hypertrophy, Left Ventricular/diagnosis/drug therapy/epidemiology/etiology
Magnetic Resonance Imaging (MRI)
Male
Middle Aged
Polycystic Kidney, Autosomal Dominant/complications/drug therapy/epidemiology
Predictive Value of Tests
Prevalence
Prospective Studies
Regression Analysis
Risk Assessment
Risk Factors
United States/epidemiology
Author Affiliation(s)
Mayo Clinic College of Medicine, Rochester, MN, US. (VET, MCH, JG)
University of Colorado Health Sciences Center, Denver, CO, US. (RWS, NP)
Emory University School of Medicine, Atlanta, GA, US. (ABC, FRO, AM, DM)
Tufts Medical Center, Boston, MA, US. (RDP, DCM, NJH)
University of Pittsburgh School of Medicine, Pittsburgh, PA, US. (KZA, JB, DK, KTB)
Kansas University Medical Center, Kansas City, KS, US. (FTW, LHW)
Cleveland Clinic, Cleveland, OH, US. (WB, ER)
Beth Israel Deaconess Medical Center, Boston, MA, US. (TIS, IP)
Washington University, St. Louis, MO, US. (JPM)
NIDDK, National Institutes of Health, Bethesda, MD, US. (CMM)
Amgen, Thousand Oaks, CA, US. (CK)
Sanford Research/USD Medical Center, Sioux Falls, South SD, US. (PAT)
ID# 742
Tags: Angiotensin II Type 1 Receptor Blockers/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Autosomal Dominant Polycystic Kidney/complications/drug therapy/epidemiology, Double-Blind Method, Female, Heart Ventricles/drug effects/pathology, Humans, Hypertension/drug therapy/epidemiology/etiology, Left Ventricular Hypertrophy/diagnosis/drug therapy/epidemiology/etiology, Magnetic Resonance Imaging (MRI), Male, Middle Aged, Predictive Value of Tests, Prevalence, Prospective Studies, Regression Analysis, Risk Assessment, Risk Factors, United States/epidemiology